Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Shares in Brammer, the UK industrial parts distributor, closed 72% higher on Wednesday after the company agreed terms of a buyout with Advent International, removing the need for a £100m emergency rights issue if the takeover is accepted by the company’s shareholders. -
ECM regular IOI Properties Group is back with a rights issue, and is looking to raise MR1.53bn ($346m) from existing shareholders. The deal is already in the bag as the Malaysian company’s largest stakeholders are all expected to sign up for the transaction.
-
Chinese biopharmaceutical company BeiGene has net $200m from a follow-on public offering of American Depositary Shares (ADSs).
-
Last week’s shock US election result caused a rout in emerging markets, with stocks and currencies in southeast Asia among the hardest hit. But unlike in the past, this has not brought equity capital markets activity to a standstill, as share sales in Indonesia, the Philippines and Thailand showed this week. John Loh reports.
-
Bayer, the German life sciences group, picked Tuesday night to launch the first part of its $19bn equity financing for its $66bn takeover of Monsanto. Bayer's deal comes as equity markets are revitalised by the new conviction that Western policy is shifting to reflation.
-
The deal the equity-linked bond market has been awaiting for months has arrived this evening. Bayer, the German life sciences group, has launched a €4bn mandatorily convertible issue as the first part of its $19bn equity financing for its takeover of Monsanto.
